Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?-Reference-Cited by-同舟云学术

Ipragliflozin and sodium glucose transporter 2 inhibitors to reduce liver fat: will the prize we sought be won?

Published:2017-12-11 Issue:3 Volume:19 Page:185-187
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Pafili Kalliopi¹,Maltezos Efstratios¹,Papanas Nikolaos¹

Affiliation:

1. Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Alexandroupolis, Greece

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1413346

Reference20 articles.

1. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions

2. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update

3. Nonalcoholic Fatty Liver Disease

4. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement

5. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of nonalcoholic fatty liver disease in Pakistan: a systematic review and meta-analysis;Scientific Reports;2024-08-23

2. Video quality of nonalcoholic fatty liver disease on TikTok: A cross-sectional study;Medicine;2024-08-23

3. Sex-Specific Association between Sodium Intake Estimated by 24-Hour Urinary Sodium Excretion and Nonalcoholic Fatty Liver Disease: The Community-Based Prospective Cohort Study;Nutrients;2024-02-16

4. Iron overload accelerated lipid metabolism disorder and liver injury in rats with non-alcoholic fatty liver disease;Frontiers in Nutrition;2022-10-11

5. Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study;Clinical Oral Investigations;2022-05-13